肌层浸润性膀胱癌化疗后未行根治性手术的预测因素:国家癌症数据库分析
基于国家癌症数据库2004–2013年4640例接受多药化疗的非转移性肌层浸润性膀胱癌患者,91%(4244例)后续接受手术。年龄增长、非裔或西班牙裔种族及诊断至化疗时间延长预测未行手术;非裔种族及Medicare/其他政府保险与化疗延迟相关。化疗延迟是可干预危险因素,应密切监测。
要点
- 年龄增长、非裔或西班牙裔种族、诊断至化疗时间延长预测化疗后未行手术。
- 非裔种族、Medicare及其他政府保险与化疗延迟相关。
- 诊断至化疗时间延长是可干预因素,应密切监测。
核心结论
- 年龄增长、非裔或西班牙裔种族及诊断至化疗时间延长预测非转移性肌层浸润性膀胱癌化疗后未行根治性手术。
研究设计与样本
- 国家癌症数据库队列研究,纳入2004–2013年cT2-4aN0M0膀胱尿路上皮癌接受多药化疗者4640例。
- 排除化疗前已手术、临床T4b及接受放疗者,采用logistic回归和Cox比例风险模型分析。
主要发现
- 4640例中4244例(91%)后续接受手术。
- 未行手术的负向预测因素:非裔种族(OR 0.58,p=0.007)、西班牙裔种族(OR 0.48,p=0.002)、年龄增长(OR 0.44,p<0.001)、诊断至化疗启动时间第四四分位>59天(OR 0.51,p<0.001)。
- 化疗延迟相关因素:非裔种族(HR 0.79,p<0.001)、Medicare(HR 0.86,p<0.001)、其他政府保险(HR 0.73,p<0.001)。
临床怎么用
- 对年龄较大、非裔或西班牙裔、诊断至化疗间隔较长者应警惕未行根治性手术的风险。
- 应密切监测并缩短诊断至新辅助化疗的等待时间,作为多模式治疗的可干预环节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Neoadjuvant chemotherapy is an important adjunct to cystectomy for managing muscle invasive bladder cancer. Using the National Cancer Database we investigated factors that predict failure to undergo surgery following multi-agent chemotherapy for nonmetastatic muscle invasive bladder cancer. MATERIALS AND METHODS: We performed a cohort study in patients diagnosed with cT2-4aN0M0 urothelial cell carcinoma of the bladder between 2004 and 2013 who underwent multi-agent chemotherapy. We excluded those with surgery prior to chemotherapy, clinical T4b disease and those who received radiotherapy. Socioeconomic and clinical predictors, including time from diagnosis to treatment, were analyzed using logistic regression for the receipt of surgery after chemotherapy. Cox proportional hazards modeling was applied to perform time dependent analysis. RESULTS: Of the 4,640 patients who met our study inclusion and exclusion criteria 4,244 (91%) proceeded to surgery. Negative predictors of surgery included African American or Hispanic race (OR 0.58, p = 0.007 and 0.48, p = 0.002, respectively), increasing age (OR 0.44, p <0.001) and greater time between diagnosis and chemotherapy initiation (fourth quartile greater than 59 days, OR 0.51, p <0.001). African American race (HR 0.79, p <0.001), Medicare (HR 0.86, p <0.001) and other government insurance (HR 0.73, p <0.001) were associated with delayed chemotherapy. CONCLUSIONS: Increasing age, African American or Hispanic race and longer time to chemotherapy predicted failure to undergo surgery. Furthermore, African American race was associated with delayed chemotherapy. Chemotherapy was also delayed in patients on Medicare or other government insurance. Longer time to neoadjuvant chemotherapy is a modifiable risk factor that should be closely observed in multimodal cancer treatment.
引用
- Kapadia AA, Martinez Acevedo A, Liu JJ, et al. Unconventional Bladder Preservation: Factors Predicting Failure to Receive Definitive Surgery following Chemotherapy for Nonmetastatic Muscle Invasive Bladder Cancer in the National Cancer Database. J Urol. 2018. PMID: 29551404. doi:10.1016/j.juro.2018.03.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。